Accuracy of diagnosis and treatment decisions for stroke, neurodegenerative disease, multiple sclerosis and brain tumor patients.
Arterys has developed Neuro AI which is a suite of clinically useful AI neuroimaging applications that provide physicians with fully automated, and easy-to-interpret customizable reporting.
It facilitates fast and accurate diagnostic and treatment decisions for stroke, neurodegenerative disease, multiple sclerosis and brain tumor patients.
Applications and diseases
Early diagnose of stroke and notification of care team. Quantification and follow up of white matter lesions for multiple sclerosis and volumetry for neurodegenerative diseases. Diagnosis and follow up of tumors with MR Perfusion and how aggressive the tumor is. It measures and visualizes flow in the brain vessels.
Neuro-oncology suite provides you with the tools to non-invasively distinguish tumor from pseudo-progression with >95% accuracy.
Accurate and consistent quantitative evaluation of MRI brain scans.
AI-driven segmentation, detection and tracking of white matter lesions on FLAIR MRI allows to accurately visualize lesions and lesion volume change over time.
Stroke suite detects and prioritizes acute LVO and ICH cases and analyzes CT and MR perfusion.